Loading...
Loading...
APM| Name | Value |
|---|---|
| Revenues | 431.4K |
| Cost of Revenue | 1,096.7K |
| Gross Profit | -665.3K |
| Operating Expense | 5,873.5K |
| Operating I/L | -6,538.9K |
| Other Income/Expense | -65.9K |
| Interest Income | 0.0K |
| Pretax | -6,604.8K |
| Income Tax Expense | -1,117.7K |
| Net Income/Loss | -5,487.1K |
Aptorum Group Limited is a biopharmaceutical company specializing in the discovery, development, and commercialization of therapeutic products for infectious diseases and cancer. The company's pipeline includes products for the treatment of neuroblastoma, various cancer types, coronavirus disease, bacterial and viral infections, metabolic diseases, and obesity. They also focus on diagnostic projects in neurology, gastroenterology, metabolic disorders, and women's health. Additionally, the company operates a medical clinic. Aptorum generates revenue through the development and commercialization of its therapeutic and diagnostic products, as well as through its medical clinic operations.
